CD98 (SLC3A2) as a novel target for receptor-mediated transcytosis at the BBB
Biological drugs over the last decade or so have revolutionised treatment options for a number of diseases. This revolution in treatments...
In vitro blood-brain barrier modelling through micro-fluidics
Understanding of the blood-brain barrier (BBB) and the impact of neuropathology on its function, is greatly facilitated by the use of in...
